Estudio primario

No clasificado

Año 2021
Registro de estudios clinicaltrials.gov

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
Mostrar resumen

This is a Prospective randomized controlled study to evaluate the difference of safety,effectiveness between chocolate balloon and plain balloon dilatation in treatment of infrapopliteal artery lesions.

Mostrar resumen

Estudio primario

No clasificado

Año 2010
Autores [No se listan los autores]
Registro de estudios UMIN Clinical Trials Registry
Cargando información sobre las referencias
Mostrar resumen

INTERVENTION:

intensive lipid lowering therapy with Pitavastatin, 1 to 4mg once daily, to achieve serum LDL cholesterol level less than 80mg/dl. conventional lipid lowering therapy with Pitavastatin, 1 to 4mg once daily, to achieve serum LDL cholesterol level less than 120mg/dl in patients without coronary heart disease or less than 100mg/dl in patients with coronary heart disease.

CONDITION:

Patients with peripheral artery disease and hypercholesterolemia

PRIMARY OUTCOME:

claudication time on Treadmill exercise test

INCLUSION CRITERIA:

1) Patient without coronary artery disease, whose LDL cholesterol >= 120mg/dl 2) Patient with coronary artery disease, whose LDL cholesterol >= 100mg/dl 3) Ankle Brachial Pressure Index (ABI) <= 0.9

Mostrar resumen

Estudio primario

No clasificado

Año 2022
Autores Wu, Y. , Tian, S. , Li, C. , Zhang, W. , Xing, Q. , Chen, G.
Revista Pain and Therapy
Cargando información sobre las referencias
Mostrar resumen

Este artículo no tiene resumen

Mostrar resumen

Estudio primario

No clasificado

Año 2020
Registro de estudios Chinese Clinical Trial Register
Cargando información sobre las referencias
Mostrar resumen

Este artículo no tiene resumen

Mostrar resumen

Estudio primario

No clasificado

Año 2024
Registro de estudios Chinese Clinical Trial Register
Cargando información sobre las referencias
Mostrar resumen

Este artículo no tiene resumen

Mostrar resumen

Estudio primario

No clasificado

Año 2023
Revista China Tropical Medicine
Cargando información sobre las referencias
Mostrar resumen

@#Abstract: Objective To investigate the fundus arteriosclerosis and its influencing factors in HIV/AIDS patients after long-term highly active antiretroviral therapy (HAART). Methods The clinical basic data and fundus examination data of 203 HIV/AIDS patients before and after HAART in the Fourth People 's Hospital of Nanning from January 2020 to June 2022 were collected to evaluate the occurrence of fundus arteriosclerosis and analyze its influencing factors. Results Of the 203 HIV/AIDS patients, 159 patients developed fundus arteriosclerosis, with an incidence of 78.33%, including 33 patients with grade Ⅰ(20.75%), 87 patients with grade Ⅱ (54.72%), 28 patients with grade Ⅲ(17.61%), and 11 patients (6.92%) with Grade Ⅳ. Before HAART, there was no significant difference in CD4+T lymphocyte count, CD8+T lymphocyte count, viral load, white blood cell count, platelet count, hemoglobin, serum creatinine, blood urea nitrogen, triacylglycerol, total cholesterol, fasting blood glucose, alanine aminotransferase, aspartate aminotransferase and serum total bilirubin between the atherosclerosis group and normal group (P>0.05). After 6 months of HAART, CD8+T lymphocyte count, triacylglycerol and fasting blood glucose in atherosclerosis group were significantly higher than those in normal group (P<0.05). In the stratified comparison of CD4+ and CD8+ lymphocyte counts after 6 months of HAART, the proportion of patients with CD4+ lymphocyte count (CD4+)<200 (cells/μL) in the atherosclerosis group was significantly higher than that in the normal group; the proportion of patients with CD4+ lymphocyte count (CD4+)≥500 (cells/μL) was significantly lower than that in the normal group; the proportion of patients with CD8+ lymphocyte count CD8+≥ 800/μL was significantly higher than that in the normal group (all P<0.05). Binary logistic regression analysis showed that opportunistic infection, HIV course, CD4+T, CD8+T lymphocyte count after HAART and triglyceride were independent risk factors for ocular fundus atherosclerosis in HIV/AIDS patients (all P<0.05). Conclusions The incidence of ocular fundus arteriosclerosis is high in HIV/AIDS patients. More than 4 years of HIV course, combined opportunistic infection, Low CD4+T lymphocyte count after 6 months of HAART, high CD8+T lymphocyte count and high triglyceride level are independent risk factors for ocular fundus arteriosclerosis in HIV/AIDS patients. Fundus screening should be performed before and after HAART in such population, HAART program should be formulated for the risk of cardiovascular disease, and risk management of cardiovascular disease should be strengthened during treatment to improve patient outcomes.

Mostrar resumen

Estudio primario

No clasificado

Año 2020
Autores Zhou B , She J , Wang Y , Ma X
Revista Journal of thrombosis and thrombolysis
Cargando información sobre las referencias
Mostrar resumen

The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December 2019, and has been declared as a public health emergency by the World Health Organization. Due to the hypercoagulable state, blood stasis and endothelial injury, severe patients with COVID-19 are at high risk for thrombosis. We report a case of very severe COVID-19 complicated with venous thrombosis and arteriosclerosis obliterans of lower extremities. Risk stratification for deep vein thrombosis and peripheral arterial disease are of vital importance for the prognosis of COVID-19.

Mostrar resumen

Estudio primario

No clasificado

Año 2006
Revista The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Cargando información sobre las referencias
Mostrar resumen

BACKGROUND:

Excessive vascular oxidant stress has been implicated in cardiac transplant-associated arteriosclerosis (TxAA). In a recent placebo-controlled study of 40 cardiac transplant recipients, vitamin C 500 mg twice a day and vitamin E 400 IU twice a day for 1 year retarded the progression of TxAA, as assessed by intravascular ultrasound (IVUS). Endothelial dysfunction is a key feature of TxAA and reflects oxidant stress. We hypothesized that coronary endothelial dysfunction portends greater TxAA progression and a larger therapeutic response to anti-oxidant vitamins.

METHODS:

In this pre-specified analysis, the 40 cardiac transplant recipients were categorized according to normal or abnormal coronary endothelial vasomotor function at baseline, as assessed by acetylcholine (10(-8) to 10(-6) mol/liter). The effect of anti-oxidant vitamins within these two groups of patients was assessed by the change in intimal index over 1 year using IVUS.

RESULTS:

With placebo (n = 21), the increase in intimal index was greater in the presence vs absence of endothelial dysfunction (11 +/- 3% vs 5 +/- 1%, p < 0.05). Among patients with endothelial dysfunction (n = 21), the intimal index increased 11 +/- 3% with placebo, but decreased -1 +/- 2% with vitamins (p = 0.002). Among patients with normal endothelial function (n = 14), the intimal index increased 5 +/- 1% with placebo and 1 +/- 1% with vitamins (p < 0.05).

CONCLUSIONS:

Endothelial dysfunction indicates rapid TxAA progression, even in the statin era. Although anti-oxidant vitamins reduce disease progression in patients with normal or abnormal endothelial function, the magnitude of benefit is larger in patients with endothelial dysfunction.

Mostrar resumen

Estudio primario

No clasificado

Año 2015
Autores [No se listan los autores]
Registro de estudios UMIN Clinical Trials Registry
Cargando información sobre las referencias
Mostrar resumen

INTERVENTION:

CTP‐15(Collagen tripeptide) 16g/BID 6months

CONDITION:

Healthy volunteers

PRIMARY OUTCOME:

FMD,CAVI SECONDARY OUTCOME:

Total‐cholesterol,HDL‐cholesterol,LDL‐cholesterol,TG; FDP,D‐D dimer

INCLUSION CRITERIA:

1. Volunteer.(Men and women over the age of 40) 2. Person who are not taking EPA. 3. Person who can obtain the document consent.

Mostrar resumen

Estudio primario

No clasificado

Año 2011
Autores Malek, F.A.
Registro de estudios ISRCTN registry
Cargando información sobre las referencias
Mostrar resumen

Este artículo no tiene resumen

Mostrar resumen